The First Nations Molecular Point-of-Care Testing Program, including TTANGO Trial, TTANGO2, TTANGO3, Aboriginal and Torres Strait Islander COVID-19 and Respiratory Infection POC Testing Programs, have been collaborations between academic research institutions, Aboriginal and government health organisations, health services, communities, pathology providers and industry.
Aboriginal community-controlled health organisations and peak bodies including:
- National Aboriginal Community Controlled Health Organisation (NACCHO)
- Aboriginal Health Council of SA
- Aboriginal Health Council of WA
- Aboriginal Health and Medical Research Council of NSW
- Aboriginal Medical Services Alliance Northern Territory
- Queensland Aboriginal and Islander Health Council
- Victorian Aboriginal Community Controlled Health Organisation
Governing Bodies including:
- First Nations Point-of Care Testing and Research Governance group
- Point-of-Care Working Group – NACCHO and the Australian Government Department of Health, Disability and Ageing
- TTANGO2 Aboriginal and Torres Strait Islander Reference Group (past)
- First Nations Infectious Diseases Point-of Care Leaders Group (past)
- National Aboriginal and Torres Strait Islander COVID-19 Advisory Group (past)
- National Aboriginal and Torres Strait Islander Health Protection Sub-committee (past)
- COVID-19 Clinical Advisory Group (past)
State and Territory health departments and other government services including:
- Australian Government Department of Health, Disability and Ageing
- Australian Centre for Disease Control
- NSW Health
- NT Health
- QLD Health
- SA Health
- VIC Health
- WA Country Health Service
- WA Health
Pathology providers including:
- St Vincent's Centre for Applied Medical Research/NSW State Reference Laboratory for HIV
- PathWest
- Pathology Queensland, including Forensic and Scientific Services
- SA Pathology
- Territory Pathology
- NSW Health Pathology
- Peter Doherty Institute for Immunity and Infection
- Microbiological Diagnostic Unit Public Health Laboratory & VIDRL
- Royal College of Pathologists of Australasia Quality Assurance Program
Industry partners including:
- Cepheid Inc
- Medical Communication Associates
- HealthLink
